Skip to search formSkip to main contentSkip to account menu

CYT 103

Known as: CYT-103 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indium 111In-satumomab pendetide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Immunoscintigraphy of colorectal carcinoma utilizing111In-labeled monoclonal antibody conjugate CYT-103
Twelve presurgical patients with colorectal carcinoma received a single intravenous infusion of 0.5–20.0 mg of the radiolabeled… 
2002
2002
Utilidad de las imágenes centelleográficas con 111In. CYT-103 en el diagnóstico de recurrencia del cáncer de colon y recto
Objetivo: Determinar la efectividad de la radioin-munocentelleografia (RIC) con 111In. CYT-103 en la deteccion de extension de… 
1998
1998
Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer
AbstractBackground: External immunoscintigraphy using a single monoclonal antibody has been employed successfully to localize… 
1997
1997
In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
In-111 CYT-103 is a tagged monoclonal antibody directed at the tumor-related antigen TAG-23 present in ovarian cancer. It is used… 
1994
1994
Detection of Recurrent Colorectal Carcinoma With In‐111 CYT‐103 Scintigraphy in a Patient With Nondiagnostic MRI and CT
Detection of recurrent colorectal carcinoma can be a diagnostic challenge. The authors report a case of a patients who, after… 
1993
1993
In‐111 CYT‐103 Immunoscintigraphy in the Imaging of Ovarian Carcinoma
Fifteen presurgical patients with a history of ovarian carcinoma were evaluated with immunoscintigraphy using the In-111-labeled… 
1993
1993
The pharmacokinetics and diagnostic accuracy of low-dose indium 111-labeled B72.3 (CYT-103) in patients with metastatic breast cancer
Review
1992
Review
1992
Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
The results of this clinical trial involving 23 sites indicated that 111In-CYT-103 immunoscintigraphy identified 70% of all… 
Highly Cited
1990
Highly Cited
1990
In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.
A phase I/II prospective clinical trial was performed with indium-111-labeled monoclonal antibody (MoAb) conjugate B72.3-glycyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)